170 related articles for article (PubMed ID: 18177235)
1. Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis.
Kinnula VL; Myllärniemi M
Antioxid Redox Signal; 2008 Apr; 10(4):727-38. PubMed ID: 18177235
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2.
Walters DM; Cho HY; Kleeberger SR
Antioxid Redox Signal; 2008 Feb; 10(2):321-32. PubMed ID: 17999635
[TBL] [Abstract][Full Text] [Related]
3. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
4. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases.
Markart P; Luboeinski T; Korfei M; Schmidt R; Wygrecka M; Mahavadi P; Mayer K; Wilhelm J; Seeger W; Guenther A; Ruppert C
Antioxid Redox Signal; 2009 Feb; 11(2):227-40. PubMed ID: 18783310
[TBL] [Abstract][Full Text] [Related]
5. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin.
Veith C; Drent M; Bast A; van Schooten FJ; Boots AW
Toxicol Appl Pharmacol; 2017 Dec; 336():40-48. PubMed ID: 28987380
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in the pathogenesis of diffuse lung diseases: a review.
Bargagli E; Olivieri C; Bennett D; Prasse A; Muller-Quernheim J; Rottoli P
Respir Med; 2009 Sep; 103(9):1245-56. PubMed ID: 19464864
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.
Kinnula VL; Fattman CL; Tan RJ; Oury TD
Am J Respir Crit Care Med; 2005 Aug; 172(4):417-22. PubMed ID: 15894605
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis.
Nagao S; Taguchi K; Sakai H; Tanaka R; Horinouchi H; Watanabe H; Kobayashi K; Otagiri M; Maruyama T
Biomaterials; 2014 Aug; 35(24):6553-62. PubMed ID: 24811261
[TBL] [Abstract][Full Text] [Related]
9. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha.
Kapanci Y; Desmouliere A; Pache JC; Redard M; Gabbiani G
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2163-9. PubMed ID: 8520791
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species.
Koli K; Myllärniemi M; Keski-Oja J; Kinnula VL
Antioxid Redox Signal; 2008 Feb; 10(2):333-42. PubMed ID: 17961070
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in particulate-induced pulmonary fibrosis; for the application of possible strategy experimentally and clinically.
Kim KA; Park CY; Lim Y; Lee KH
Curr Drug Targets; 2000 Nov; 1(3):297-307. PubMed ID: 11465077
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy.
Varone F; Gibiino G; Gasbarrini A; Richeldi L
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6379-6386. PubMed ID: 31364146
[TBL] [Abstract][Full Text] [Related]
13. Role of oxidative stress in pulmonary fibrosis.
Mastruzzo C; Crimi N; Vancheri C
Monaldi Arch Chest Dis; 2002; 57(3-4):173-6. PubMed ID: 12619377
[TBL] [Abstract][Full Text] [Related]
14. Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression.
Tanaka R; Watanabe H; Kodama A; Chuang VT; Ishima Y; Hamasaki K; Tanaka K; Mizushima T; Otagiri M; Maruyama T
J Pharmacol Exp Ther; 2013 May; 345(2):271-83. PubMed ID: 23442250
[TBL] [Abstract][Full Text] [Related]
15. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis.
Cantin AM; Hubbard RC; Crystal RG
Am Rev Respir Dis; 1989 Feb; 139(2):370-2. PubMed ID: 2913886
[TBL] [Abstract][Full Text] [Related]
16. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.
Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA
Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215
[TBL] [Abstract][Full Text] [Related]
17. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
18. [The expressions and meanings of BMP-7 and TGF-β in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia].
Gu P; Luo B; Yi X; Zhu H; Li S; Yu X; Han F; Zhang S; Zhu X; Rui W; Qiu W; Fan D
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Sep; 37(9):664-70. PubMed ID: 25533688
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of transforming growth factor-β signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis.
Lilja-Maula L; Syrjä P; Laurila HP; Sutinen E; Rönty M; Koli K; Rajamäki MM; Myllärniemi M
J Comp Pathol; 2014 May; 150(4):399-407. PubMed ID: 24529509
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
